ReviewPreventive medicine reports2020
Strengths and weaknesses of existing data sources to support research to address the opioids crisis.
Review in Preventive medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Opioid Misuse and Suicide-Related Outcomes Among Adolescents and Young Adults: A Systematic Review.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2025Pooled it
- Interactive network visualization of opioid crisis research: a tool for reinforcing data linkage skills for public health policy researchers.Frontiers in artificial intelligence · 2024Pooled it
- Choosing an analytic approach: key study design considerations in state policy evaluation.Health services & outcomes research methodology · 2026Article
- Surface swabbing of nightclub venues to monitor the presence of cocaine, ketamine, and MDMA.The American journal of drug and alcohol abuse · 2026Article
- Creating a Classification System of Opioid Use Disorder Treatment Policies: A Research Protocol.Substance use & addiction journal · 2025Article
- Fair allocation strategies for opioid settlements.Health care management science · 2025Article
- Estimates of Illicit Opioid Use in the US.JAMA health forum · 2025Article
- Implementation of Overdose Prevention in Maryland: Implications for Resource Allocation, Program Scale-Up, and Evaluation.Health promotion practice · 2025Article
- Exploring unregulated substance use health data in Ontario, Canada: Identifying gaps, addressing challenges, and uncovering opportunities.Frontiers in public health · 2025Article
- Assessment of Epidemiological Data and Surveillance in Korea Substance Use Research: Insights and Future Directions.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2024Review
- Article
- Concordance of opioid exposure in all-payer claims databases with prescription drug monitoring program database using Arkansas as a case example.Health services research · 2023Article
- Systematic Identification and Categorization of Opioid Prescribing and Dispensing Policies in 16 States and Washington, DC.Pain medicine (Malden, Mass.) · 2023Article
- Development and testing of data infrastructure in the American College of Emergency Physicians' Clinical Emergency Data Registry for opioid-related research.Journal of the American College of Emergency Physicians open · 2022Article
- Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder.JAMA health forum · 2022Article
- Considerations for observational study design: Comparing the evidence of opioid use between electronic health records and insurance claims.Pharmacoepidemiology and drug safety · 2022Article
- Ethical by Design: Engaging the Community to Co-design a Digital Health Ecosystem to Improve Overdose Prevention Efforts Among Highly Vulnerable People Who Use Drugs.Frontiers in digital health · 2022Article
- Trends in visits to substance use disorder treatment facilities in 2020.Journal of substance abuse treatment · 2021Review
- Linkage of public health and all payer claims data for population-level opioid research.Pharmacoepidemiology and drug safety · 2021Article
- Methodological Challenges and Proposed Solutions for Evaluating Opioid Policy Effectiveness.Health services & outcomes research methodology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Better opioid prescribing practices, promoting effective opioid use disorder treatment, improving naloxone access, and enhancing public health surveillance are strategies central to reducing opioid-related morbidity and mortality. Successfully advancing and evaluating these strategies requires leveraging and linking existing secondary data sources. We conducted a scoping study in Fall 2017 at RAND, including a literature search (updated in December 2018) complemented by semi-structured interviews with policymakers and researchers, to identify data sources and linking strategies commonly used in opioid studies, describe data source strengths and limitations, and highlight opportunities to use data to address high-priority public health research questions. We identified 306 articles, published between 2005 and 2018, that conducted secondary analyses of existing data to examine one or more public health strategies. Multiple secondary data sources, available at national, state, and local levels, support such research, with substantial breadth in data availability, data contents, and the data's ability to support multi-level analyses over time. Interviewees identified opportunities to expand existing capabilities through systematic enhancements, including greater support to states for creating and facilitating data use, as well as key data challenges, such as data availability lags and difficulties matching individual-level data over time or across datasets. Multiple secondary data sources exist that can be used to examine the impact of public health approaches to addressing the opioid crisis. Greater data access, improved usability for research purposes, and data element standardization can enhance their value, as can improved data availability timeliness and better data comparability across jurisdictions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.